Regional Kidney Paired Donor Exchange in Sensitized Patients

NCT ID: NCT01896089

Last Updated: 2016-09-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective, multi-center, observational study to determine if a combination of desensitization and enrollment in a regional kidney paired donor (KPD) exchange program improves the overall rate of kidney transplantation in sensitized patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

The Rate of Kidney Transplants in Sensitized Patients.

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Willing and able to sign an informed consent form
2. Must be at least 18 years old
3. Meet all recipient selection criteria of the transplant center
4. Listed on the deceased donor kidney waiting list for renal transplant at a participating center
5. Potential recipients must:

Group 1: have one or more medically suitable donors who are ABO incompatible or HLA incompatible (defined as positive serologic cross-match); or

Group 2: have a medically suitable donor that is otherwise deemed incompatible due to age, size, or other mismatch by their respective transplant center; or

Group 3: be listed on the deceased donor waiting list for ≥ one year without an identifiable living donor and have a PRA% ≥ 60%


1. Must provide informed consent in accordance with the process outlined in the Informed Consent Requirements Section of the KPD Program Manual of Operations
2. Must be at least 18 years old
3. Meet all living donor selection criteria of the transplant center
4. Meet the evaluation requirements set forth in the Living Donor Evaluation Section of the KPD Program Operational Guidelines

Exclusion Criteria

* C. Recipients

1. Do not meet selection criteria of the transplant center
2. Eligible compatible donor at the time of enrollment
3. Inactive (not eligible to receive a kidney) on the deceased donor waitlist
4. Pregnant or breast feeding

D. Donors

1. Unwilling or unable to provide informed consent
2. Have identified barriers to donation as set forth in the Living Donor Evaluation Section of the KPD Program Manual of Operations (Appendix A)
3. Must not be currently listed as a potential living donor for any other recipient registered in the KPD system
4. Pregnant or breast feeding
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

BiologicTx, LLC

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lisa Florence, MD

Role: PRINCIPAL_INVESTIGATOR

Swedish Medical Center

Andrew Weiss, MD

Role: PRINCIPAL_INVESTIGATOR

Virginia Mason Medical Center

Douglas Norman, MD

Role: PRINCIPAL_INVESTIGATOR

Oregon Health and Science University

Richard Carson, MD

Role: PRINCIPAL_INVESTIGATOR

Sacred Heart Medical Center (Spokane)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Virginia Mason Medical Center

Seattle, Washington, United States

Site Status RECRUITING

Swedish Medical Center

Seattle, Washington, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Donald Rodriguez

Role: primary

206-342-6958

Terri Spinelli

Role: primary

206-215-3063

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KPD6172013

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Live Kidney Donor Study
NCT00608283 COMPLETED